The results of a randomized, controlled trial investigating the neurocognitive effects of stereotactic radiosurgery (SRS), with or without whole-brain radiation therapy (WBRT), to treat brain metastases demonstrated a significant reduction in learning and memory, associated with the addition of WBRT to SRS. The results indicate that SRS monotherapy is an effective and safe initial management strategy for brain metastases.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Using lithium as a neuroprotective agent in patients with cancer
BMC Medicine Open Access 02 November 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Brown, P. D., Asher, A. L. & Farace, E. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed. Int. J. Radiat. Oncol. Biol. Phys. 70, 1305–1309 (2008).
Meyers, C. A. & Brown, P. D. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J. Clin. Oncol. 24, 1305–1309 (2006).
Chang, E. L. et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 10, 1037–1044 (2009).
Patchell, R. A. et al. A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med. 322, 494–500 (1990).
Aoyama, H. et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int. J. Radiat. Oncol. Biol. Phys. 68, 1388–1395 (2007).
Regine, W. F. et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int. J. Radiat. Oncol. Biol. Phys. 52, 333–338 (2002).
Andrews, D. W. et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363, 1665–1672 (2004).
Regine, W. F., Scott, C., Murray, K. & Curran, W. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91–04. Int. J. Radiat. Oncol. Biol. Phys. 51, 711–717 (2001).
Sneed, P. K. et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 53, 519–526 (2002).
Aoyama, H. et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295, 2483–2491 (2006).
Acknowledgements
This research was supported in part by Grant W81XWH-062-0033 from the US Department of Defense Breast Cancer Research Program to R. J. Weil. We wish to thank the M. Burkhardt, Chair in neurosurgical oncology and the Karen Colina Wilson research endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic Foundation for additional support and funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Marko, N., Weil, R. Neurocognitive considerations in the treatment of brain metastases. Nat Rev Clin Oncol 7, 185–186 (2010). https://doi.org/10.1038/nrclinonc.2010.30
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2010.30
This article is cited by
-
A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone
Strahlentherapie und Onkologie (2014)
-
A simple survival score for patients with brain metastases from breast cancer
Strahlentherapie und Onkologie (2013)
-
A new survival score for patients with brain metastases from non-small cell lung cancer
Strahlentherapie und Onkologie (2013)
-
Using lithium as a neuroprotective agent in patients with cancer
BMC Medicine (2012)
-
Prophylactic cranial irradiation: the state of the art and areas of uncertainty
Clinical and Translational Oncology (2012)